Dr James E Campbell, PHARMD in Sedan, KS - Pharmacist

Dr James E Campbell, PHARMD is a Pharmacist based in Sedan, Kansas. Dr James E Campbell is licensed to practice in Kansas (license number 1-13647) and his current practice location is 129 E Main St, Sedan, Kansas. He can be reached at his office (for appointments etc.) via phone at (620) 725-3262.

NPI number for Dr James E Campbell is 1831572551 and his current mailing address is 129 E Main St, Sedan, Kansas. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1831572551.

Contact Information

	Dr James E Campbell, PHARMD
	129 E Main St, Sedan, KS 67361-1626
	(620) 725-3262
	(620) 725-3110

Healthcare Provider's Profile

Full Name	Dr James E Campbell
Gender	Male
Speciality	Pharmacist
Location	129 E Main St, Sedan, Kansas
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1831572551
Provider Enumeration Date: 06/30/2015
Last Update Date: 06/30/2015

Medical Identifiers

Medical identifiers for Dr James E Campbell such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1831572551	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	1-13647 (Kansas)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr James E Campbell is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr James E Campbell, PHARMD 129 E Main St, Sedan, KS 67361-1626 Ph: (620) 725-3262	Dr James E Campbell, PHARMD 129 E Main St, Sedan, KS 67361-1626 Ph: (620) 725-3262

News Archive

Growth factor TGF-beta helps maintain health of retinal blood vessels

Scientists at Schepens Eye Research Institute have found that the growth factor known as TGF-beta is essential to the health of blood vessels in the retina and that blocking it can cause retinal dysfunction.

Deep brain stimulation benefits highly treatment resistant patients with major depressive disorder

Results from the first multi-center pilot study of deep brain stimulation (DBS) for major depressive disorder were published online today by the Journal of Neurosurgery. The study, conducted at three research facilities in Canada, was designed to replicate and build upon an earlier study by Dr. Andres Lozano and Dr. Helen Mayberg which was published in the journal Neuron in 2005.

Using Smartphones for Cancer Diagnosis and Management

Dr. Castro is a translational oncologist with experience developing and harnessing nanotechnology and molecular imaging platforms for cancer purposes. His work offers a "less is more" approach — to generate robust cancer analyses using scant amount of specimens. Dr. Castro's research has included funding from the V Foundation for Cancer Research, National Institutes of Health, Ovarian Cancer Research Fund, and the Department of Defense.

ESHRE workshop on human reproduction, more specifically on the freezing of sperm and embryos

ESHRE invites you to attend its workshop on freezing of human sperm, eggs and embryos in Athens, Greece "Cryobiology and cryopreservation of human gametes and embryos".

Inhibition of Meprin Β enzyme can trigger the development of Alzheimer's disease, cancer

Researchers at Johannes Gutenberg University Mainz (JGU) in Germany and the Institute of Molecular Biology of Barcelona in Spain have discovered how the blood plasma protein fetuin-B binds to the enzyme meprin β and used a computer model to visualize their findings.

Dr James E Campbell, PHARMD - Pharmacist in Sedan, KS